Therapy News and Research

RSS

MSU to launch levetiracetam clinical trial for treatment of African children with epilepsy

Determined to bring relief to seizure victims, a Michigan State University research team this month begins a groundbreaking clinical drug trial that could help prevent a quarter-million African children from developing epilepsy each year.

16 Feb 2013

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Genzyme, a Sanofi company, today announced positive new data from the Phase 3 ENGAGE and ENCORE studies of eliglustat tartrate, its investigational oral therapy for Gaucher disease type 1.

15 Feb 2013

Depression reduces efficacy of shingles vaccine

Research suggests that the varicella zoster, or shingles, vaccine is less effective in older people with untreated depression.

15 Feb 2013

Tumor texture analysis has prognostic potential

Tumor texture analysis, determined by computed tomography, holds promise as a prognostic biomarker in patients with esophageal cancer, research indicates.

15 Feb 2013

Artificial pancreas improves on insulin pump therapy in Type 1 diabetes

The dual-hormone closed-loop delivery system, a type of artificial pancreas, could offer significant advantages over conventional insulin pump therapy in Type 1 diabetes patients, report researchers.

15 Feb 2013

Nightmare of insomnia could explain suicide link in patients with depression

The link between insomnia and suicidal thoughts in patients with depression may be mediated by nightmares and dysfunctional beliefs and attitudes about sleep, research suggests.

15 Feb 2013

Surprises found in postoperative pain rankings

Patients report “unexpectedly high” levels of pain after some relatively minor surgical procedures, including some laparoscopic procedures, say researchers.

15 Feb 2013

Frequent dialysis: it’s complicated

Patients who undergo hemodialysis on a frequent basis are at an increased risk for vascular access complications, requiring more vascular repair procedures to enable continued access to the blood, report Canadian researchers.

15 Feb 2013

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

United Health Products, Inc.'s www.unitedhealthproductsinc.com wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp.

15 Feb 2013

New progestogen-only treatment effective in stopping acute abnormal uterine bleeding

New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.

15 Feb 2013

Researchers identify new molecular pathway involved in alveoli growth

In a study of mice, researchers at Johns Hopkins have identified a new molecular pathway involved in the growth of tiny air sacs called alveoli that are crucial for breathing. The scientists say their experiments may lead to the first successful treatments to regrow the air sacs in people who suffer from diseases such as emphysema in which the air sacs have been destroyed by years of smoking.

15 Feb 2013

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

TB is an infectious disease caused by Mycobacterium tuberculosis. Nearly 9 million people develop TB every year, and TB kills nearly 1.4 million individuals each year. While the incidence of TB has steadily declined in the west, it remains a huge public health problem in many developing countries, with India having the highest burden.

15 Feb 2013

Researchers show how gene mutations shift and evolve over time in chronic lymphocytic leukemia

Tumors are not factories for the mass production of identical cancer cells, but are, in reality, patchworks of cells with different patterns of gene mutations. In a new study, researchers at Dana-Farber Cancer Institute and the Broad Institute show, more fully than ever before, how these mutations shift and evolve over time in chronic lymphocytic leukemia (CLL) - providing a strobe-like look at the genetic past, present, and future of CLL tumors.

15 Feb 2013

Dompé initiates enrollment in rhNGF phase I/II REPARO study for neurotrophic keratitis

The first patient has been enrolled in the phase I/II REPARO study, the first international clinical trial evaluating the ophthalmological use of a topical solution of recombinant human Nerve Growth Factor (rhNGF) for the treatment of moderate to severe neurotrophic keratitis (NK).

15 Feb 2013

Pivotal Response Treatment improves brain activity in children with autism

Using functional magnetic resonance imaging (fMRI) for before-and-after analysis, a team of researchers including a UC Santa Barbara graduate student discovered positive changes in brain activity in children with autism who received a particular type of behavioral therapy.

15 Feb 2013

Therapy News and Research

MSU to launch levetiracetam clinical trial for treatment of African children with epilepsy

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Depression reduces efficacy of shingles vaccine

Tumor texture analysis has prognostic potential

Artificial pancreas improves on insulin pump therapy in Type 1 diabetes

Nightmare of insomnia could explain suicide link in patients with depression

Surprises found in postoperative pain rankings

Frequent dialysis: it’s complicated

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

New progestogen-only treatment effective in stopping acute abnormal uterine bleeding

Researchers identify new molecular pathway involved in alveoli growth

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

Researchers show how gene mutations shift and evolve over time in chronic lymphocytic leukemia

Dompé initiates enrollment in rhNGF phase I/II REPARO study for neurotrophic keratitis

Pivotal Response Treatment improves brain activity in children with autism

Cardinal Health announces plans to acquire AssuraMed

ASGCT to honor UNC genetics professor with 2013 Outstanding New Investigator Award

Elemental diet may help adults with eosinophilic esophagitis

US health system failing unaccompanied immigrant children

Endovascular stroke therapy disappoints in head-to-head studies

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News